MGLU 2/3 AGONISTS
The present invention provides novel mGlu2/3 agonists of the formula wherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; pol |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PRIETO LOURDES CLARK BARRY PETER MONN JAMES ALLEN BAKER STEPHEN RICHARD BEADLE CHRISTOPHER DAVID |
| description | The present invention provides novel mGlu2/3 agonists of the formula wherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2809647TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2809647TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2809647TT33</originalsourceid><addsrcrecordid>eNrjZBD0dfcJVTDSN1ZwdPf38wwOCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEBPkYWBpZmJuYhIcbGxKgBAAkpHfs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MGLU 2/3 AGONISTS</title><source>esp@cenet</source><creator>PRIETO LOURDES ; CLARK BARRY PETER ; MONN JAMES ALLEN ; BAKER STEPHEN RICHARD ; BEADLE CHRISTOPHER DAVID</creator><creatorcontrib>PRIETO LOURDES ; CLARK BARRY PETER ; MONN JAMES ALLEN ; BAKER STEPHEN RICHARD ; BEADLE CHRISTOPHER DAVID</creatorcontrib><description>The present invention provides novel mGlu2/3 agonists of the formula wherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders.</description><language>eng ; pol</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170731&DB=EPODOC&CC=PL&NR=2809647T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170731&DB=EPODOC&CC=PL&NR=2809647T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PRIETO LOURDES</creatorcontrib><creatorcontrib>CLARK BARRY PETER</creatorcontrib><creatorcontrib>MONN JAMES ALLEN</creatorcontrib><creatorcontrib>BAKER STEPHEN RICHARD</creatorcontrib><creatorcontrib>BEADLE CHRISTOPHER DAVID</creatorcontrib><title>MGLU 2/3 AGONISTS</title><description>The present invention provides novel mGlu2/3 agonists of the formula wherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD0dfcJVTDSN1ZwdPf38wwOCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEBPkYWBpZmJuYhIcbGxKgBAAkpHfs</recordid><startdate>20170731</startdate><enddate>20170731</enddate><creator>PRIETO LOURDES</creator><creator>CLARK BARRY PETER</creator><creator>MONN JAMES ALLEN</creator><creator>BAKER STEPHEN RICHARD</creator><creator>BEADLE CHRISTOPHER DAVID</creator><scope>EVB</scope></search><sort><creationdate>20170731</creationdate><title>MGLU 2/3 AGONISTS</title><author>PRIETO LOURDES ; CLARK BARRY PETER ; MONN JAMES ALLEN ; BAKER STEPHEN RICHARD ; BEADLE CHRISTOPHER DAVID</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2809647TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2017</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PRIETO LOURDES</creatorcontrib><creatorcontrib>CLARK BARRY PETER</creatorcontrib><creatorcontrib>MONN JAMES ALLEN</creatorcontrib><creatorcontrib>BAKER STEPHEN RICHARD</creatorcontrib><creatorcontrib>BEADLE CHRISTOPHER DAVID</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PRIETO LOURDES</au><au>CLARK BARRY PETER</au><au>MONN JAMES ALLEN</au><au>BAKER STEPHEN RICHARD</au><au>BEADLE CHRISTOPHER DAVID</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MGLU 2/3 AGONISTS</title><date>2017-07-31</date><risdate>2017</risdate><abstract>The present invention provides novel mGlu2/3 agonists of the formula wherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; pol |
| recordid | cdi_epo_espacenet_PL2809647TT3 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | MGLU 2/3 AGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T04%3A43%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PRIETO%20LOURDES&rft.date=2017-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2809647TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |